Skip to content
10-Q

Quarterly Report

BARINTHUS BIOTHERAPEUTICS PLC BRNS

0001828185-25-000072

← back to feed
Filed
Nov 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 30, 2025 40.83M sh
Shares Diluted Q3 2025 · Sep 30, 2025 40.66M sh
Shares Diluted Q3 2025 · Sep 30, 2025 40.42M sh
Shares Diluted Q3 2025 · Sep 30, 2024 39.42M sh
Shares Diluted Q3 2025 · Sep 30, 2024 39.08M sh
Capex Q3 2025 · Sep 30, 2025 $37K
Capex Q3 2025 · Sep 30, 2024 $614K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$43.74M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$42.03M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $74.27M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $110.66M
Stockholders Equity Q3 2025 · Sep 30, 2025 $84.47M
Stockholders Equity Q3 2025 · Dec 31, 2024 $130.03M
Current Liabilities Q3 2025 · Sep 30, 2025 $10.8M
Current Liabilities Q3 2025 · Dec 31, 2024 $15.66M
Total Liabilities Q3 2025 · Sep 30, 2025 $24.64M
Total Liabilities Q3 2025 · Dec 31, 2024 $30.19M
Current Assets Q3 2025 · Sep 30, 2025 $86.78M
Current Assets Q3 2025 · Dec 31, 2024 $125.74M
Total Assets Q3 2025 · Sep 30, 2025 $109.2M
Total Assets Q3 2025 · Dec 31, 2024 $160.33M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.36
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.37
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.21
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.04
Eps Basic Q3 2025 · Sep 30, 2025 −$0.36
Eps Basic Q3 2025 · Sep 30, 2025 −$1.37
Eps Basic Q3 2025 · Sep 30, 2024 −$0.21
Eps Basic Q3 2025 · Sep 30, 2024 −$1.04
Sga Expense Q3 2025 · Sep 30, 2025 $5.17M
Sga Expense Q3 2025 · Sep 30, 2025 $33.19M
Sga Expense Q3 2025 · Sep 30, 2024 $13.42M
Sga Expense Q3 2025 · Sep 30, 2024 $26.62M
Rd Expense Q3 2025 · Sep 30, 2025 $5.39M
Rd Expense Q3 2025 · Sep 30, 2025 $21.63M
Rd Expense Q3 2025 · Sep 30, 2024 $11.14M
Rd Expense Q3 2025 · Sep 30, 2024 $33.93M
Net Income Q3 2025 · Sep 30, 2025 −$14.57M
Net Income Q3 2025 · Sep 30, 2025 −$55.34M
Net Income Q3 2025 · Sep 30, 2024 −$8.11M
Net Income Q3 2025 · Sep 30, 2024 −$40.53M
Operating Income Q3 2025 · Sep 30, 2025 −$15.07M
Operating Income Q3 2025 · Sep 30, 2025 −$58.99M
Operating Income Q3 2025 · Sep 30, 2024 −$9.38M
Operating Income Q3 2025 · Sep 30, 2024 −$44.58M
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2025 $0
Revenue Q3 2025 · Sep 30, 2024 $14.97M
Revenue Q3 2025 · Sep 30, 2024 $14.97M